CD19 and systemic lupus erythematosus: Interestingly, although all patients were in drug-free remissions at 3 months post-infusion, many of patient 4’s SLE-associated antibodies did not decrease following anti-CD19 CAR T cell infusion (Figures 2A and S1).8